Modulation of Adhesion Molecules in Patients with AML During Immunotherapy with IL-2

  • K. Fenchel
  • L. Bergmann
  • B. Jahn
  • P. S. Mitrou
Conference paper
Part of the Haematology and Blood Transfusion / Hämatologie und Bluttransfusion book series (HAEMATOLOGY, volume 36)


Cell-to-cell interactions in the immune system are mediated by several different families of receptors on the cell surface, known as adhesion molecules. These adhesion molecules influence many diverse processes including growth, differentiation, migration, and killer-target cell interactions. To fulfill these effects, the density and the expression of these glycoproteins varies in relation to the cellular state of activation. The expression of these adhesion molecules is shown to be modulated by interferon gamma (IFN-γ), tumor necrosis factor alpha (TNF-α), interleukin (IL) 1,4, and 7 [1–3]. IL-2 has been shown to induce an upregulation of some adhesion molecules in vitro [4]. However, it remains unclarified, whether this modulation is mediated by IL-2 itself or by release of secondary cytokines. Additional, no data are available so far concerning the modulation of adhesion molecules after immunotherapy with IL-2. In this study we focussed our interest on the expression of adhesion molecules on peripheral blood lymphocytes (PBL) and the serum levels of soluble CD54 (ICAM-1) in vivo after immunotherapy with IL-2.


Adhesion Molecule Acute Myelocytic Leukemia Peripheral Blood Lymphocyte Soluble CD54 Adhesion Molecule Expression 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Barker J, Sarma V, Mitra RS, Dixit VM, Nickoloff BJ (1990) Marked Synergism between Tumor Necrosis Factor-α and Interferon-γ in regulation of keratinocyte-derived adhesion molecules and chemotactic factors. J Clin Invest 85: 605–608PubMedCrossRefGoogle Scholar
  2. 2.
    Stotter H, Custer MC, Bolton ES, Guedez L, Lotze MT (1991) IL-7 induces human lymphokineactivated killer cell activity and is regulated by IL-4. J Immunology 146 (1): 150–155Google Scholar
  3. 3.
    Norris DA (1990) Cytokine modulation of adhesion molecules in the regulation of immuno. logic cytotoxicity of epidermal targets. J Invest Dermatol 95(6): 111S–120SPubMedCrossRefGoogle Scholar
  4. 4.
    Buckle AM, Hogg N (1990) Human memory T cells express intercellular adhesion molecule-1 which can be increased by interleukin 2 and interferon-γ. Eur J Immunol 20: 337–341PubMedCrossRefGoogle Scholar
  5. 5.
    Weidmann E, Bergmann L, Hechler P, Mitrou PS (1991) Cytotoxic activity and phenotypic characteristics of lymphocyte subsets after therapy of cancer patients with interleukin-2. Cancer Immunol Immunother 33: 398–402PubMedCrossRefGoogle Scholar
  6. 6.
    Rothlein R, Mainolfi EA, Czajkowski M, Marlin SD (1991) A form of circulating ICAM-1 in human serum. J Immunol 147(11): 3788–3793PubMedGoogle Scholar
  7. 7.
    Archimbaud E, Bailly M, Dore JF (1990) Inducibility of lymphokine activated killer (LAK) cells in patients with acute myelogenous leukemia in complete remission and its clinical relevance. Brit J Haematol 77: 328–334CrossRefGoogle Scholar
  8. 8.
    Foa R, Meloni G, Tosti S, Fierro MT, Gavosto F, Mandelli F (1989) Recombinant IL2 in the treatment of acute leukemia: a pilot study. Blood 74: 357aGoogle Scholar
  9. 9.
    Bergmann L, Mitrou PS, Hoelzer D (1992) Interleukin-2 in the treatment of acute myelocytic leukemias: in vitro data and presentation of a clinical concept. In: Haematology and Blood Transfusion 34, Hiddemann et al. (Eds.), Springer Verlag, Berlin, 601–607Google Scholar
  10. 10.
    Fenchel K, Bergmann L, Martin H, Jahn B, Mitrou PS, Hoelzer D (1991) Clinical and biological effects of Interleukin-2 as late consolidation therapy in 2nd remission of acute myelocytic leukemia with and without autologous bone marrow transplantation. Haematologica Vol. 76(4): 55Google Scholar
  11. 11.
    Wang P, Vanky F, Li SL, Patarroyo M, Klein E (1990) Functional characteristics of the intercellular adhesion molecule-1 (CD 54) expressed on cytotoxic human blood lymphocytes. Cell-Immunol 131(2): 366–380PubMedCrossRefGoogle Scholar
  12. 12.
    Geissler D, Gaggl S, Most J, Greil R, Herold M, Dietrich M (1990) A monoclonal antibody directed against the human intercellular adhesion molecule (ICAM-1) modulates the release of tumor necrosis factor alpha, interferon gamma, and interIeukin-1. Eur J Immunol 20(12): 2591–2596PubMedCrossRefGoogle Scholar
  13. 13.
    Weidmann E, Bergmann L, Stock J, Kirsten R, Mitrou PS (1991) Cytokine release in cancer patients treated with interleukin-2. J Immunotherapy (in press)Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1994

Authors and Affiliations

  • K. Fenchel
    • 1
  • L. Bergmann
    • 1
  • B. Jahn
    • 1
  • P. S. Mitrou
    • 1
  1. 1.Div. of Hematology, Dpt. of Internal MedicineJ. W. Goethe - UniversityFrankfurt/MGermany

Personalised recommendations